These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8633072)

  • 1. Stable triple helices formed by oligonucleotide N3'-->P5' phosphoramidates inhibit transcription elongation.
    Escudé C; Giovannangeli C; Sun JS; Lloyd DH; Chen JK; Gryaznov SM; Garestier T; Hélène C
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4365-9. PubMed ID: 8633072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient inhibition of transcription elongation in vitro by oligonucleotide phosphoramidates targeted to proviral HIV DNA.
    Giovannangeli C; Perrouault L; Escudé C; Gryaznov S; Hélène C
    J Mol Biol; 1996 Aug; 261(3):386-98. PubMed ID: 8780781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligonucleotide n3'-->p5' phosphoramidates and thio-phoshoramidates as potential therapeutic agents.
    Gryaznov SM
    Chem Biodivers; 2010 Mar; 7(3):477-93. PubMed ID: 20232321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Lloyd DH; Chen JK; Schultz RG; DeDionisio LA; Ratmeyer L; Wilson WD
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):5798-802. PubMed ID: 7541136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligo-2'-fluoro-2'-deoxynucleotide N3'-->P5' phosphoramidates: synthesis and properties.
    Schultz RG; Gryaznov SM
    Nucleic Acids Res; 1996 Aug; 24(15):2966-73. PubMed ID: 8760881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of oligodeoxyribonucleotide N3'-->P5' phosphoramidates.
    Chen JK; Schultz RG; Lloyd DH; Gryaznov SM
    Nucleic Acids Res; 1995 Jul; 23(14):2661-8. PubMed ID: 7651827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural RNA mimetics: N3'-->P5' phosphoramidate DNA analogs of HIV-1 RRE and TAR RNA form A-type helices that bind specifically to Rev and Tat-related peptides.
    Rigl CT; Lloyd DH; Tsou DS; Gryaznov SM; Wilson WD
    Biochemistry; 1997 Jan; 36(3):650-9. PubMed ID: 9012680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligonucleotide N3'-->P5' phosphoramidates as potential therapeutic agents.
    Gryaznov SM
    Biochim Biophys Acta; 1999 Dec; 1489(1):131-40. PubMed ID: 10807003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription inhibition induced by modified triple helix-forming oligonucleotides: a quantitative assay for evaluation in cells.
    Faria M; Wood CD; White MR; Hélène C; Giovannangeli C
    J Mol Biol; 2001 Feb; 306(1):15-24. PubMed ID: 11178890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligonucleotide directed triple helix formation.
    Sun JS; Garestier T; Hélène C
    Curr Opin Struct Biol; 1996 Jun; 6(3):327-33. PubMed ID: 8804836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and properties of RNA analogs-oligoribonucleotide N3'-->P5' phosphoramidates.
    Matray TJ; Gryaznov SM
    Nucleic Acids Res; 1999 Oct; 27(20):3976-85. PubMed ID: 10497261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-specific control of gene expression by antigene and clamp oligonucleotides.
    Hélène C; Giovannangeli C; Guieysse-Peugeot AL; Praseuth D
    Ciba Found Symp; 1997; 209():94-102; discussion 102-6. PubMed ID: 9383571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loop-loop interaction of HIV-1 TAR RNA with N3'-->P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription.
    Darfeuille F; Arzumanov A; Gryaznov S; Gait MJ; Di Primo C; Toulmé JJ
    Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9709-14. PubMed ID: 12105271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific inhibition of in vitro transcription elongation by triplex-forming oligonucleotide-intercalator conjugates targeted to HIV proviral DNA.
    Giovannangeli C; Perrouault L; Escudé C; Nguyen T; Hélène C
    Biochemistry; 1996 Aug; 35(32):10539-48. PubMed ID: 8756710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An oligodeoxyribonucleotide N3'--> P5' phosphoramidate duplex forms an A-type helix in solution.
    Ding D; Grayaznov SM; Lloyd DH; Chandrasekaran S; Yao S; Ratmeyer L; Pan Y; Wilson WD
    Nucleic Acids Res; 1996 Jan; 24(2):354-60. PubMed ID: 8628662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamic and kinetic effects of N3'-->P5' phosphoramidate modification on pyrimidine motif triplex DNA formation.
    Torigoe H
    Biochemistry; 2001 Jan; 40(4):1063-9. PubMed ID: 11170429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcription.
    Boulmé F; Freund F; Moreau S; Nielsen PE; Gryaznov S; Toulmé JJ; Litvak S
    Nucleic Acids Res; 1998 Dec; 26(23):5492-500. PubMed ID: 9826777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.